Physician

Rachel Vivian Kramer, M.D.

According to 2025 Medicare claims, Rachel Kramer, M.D. (NPI: 1932108875) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is EAST SIDE ONCOLOGY ASSOCIATES PLLC DBA AMERICAN INFUSION CENTER (NPI: 1922287390; TIN: 421742483) and primary practice location at 10128-6828.

Kramer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,150 traditional Medicare patients, billed 266,171 HCPCS/CPT codes, and received $3,739,196 in Medicare payments. The top billing code was 96401 (Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle). Part D data shows 196 prescription claims across 47 beneficiaries totaling $170,294 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 104 records totaling $2,268. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $797,555 to $3,739,196. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $223,699 and ending at $170,294. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	279	57,841	$797,555
2017	517	131,124	$1,814,414
2018	612	204,073	$2,909,571
2019	632	206,957	$2,545,797
2020	693	178,161	$2,215,521
2021	643	177,127	$2,683,095
2022	833	239,716	$2,937,660
2023	932	229,180	$2,989,049
2024	1,150	266,171	$3,739,196

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	533	$223,699
2016	69	364	$184,145
2017	64	271	$127,634
2018	64	244	$167,778
2019	55	179	$100,408
2020	54	191	$356,658
2021	62	229	$529,174
2022	48	237	$353,672
2023	40	202	$255,435
2024	47	196	$170,294

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	733	1,338	$68
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	847	1,419	$51
J0897	Injection, denosumab, 1 mg	632	51,360	$21
36415	Insertion of needle into vein for collection of blood sample	399	991	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	310	900	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	25	960	$20,014
Hydroxyurea	Hydroxyurea	25	1,566	$587
Anastrozole	Anastrozole	15	1,290	$337
Tamoxifen Citrate	Tamoxifen Citrate	16	960	$297
Zolpidem Tartrate	Zolpidem Tartrate	13	390	$133

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	104	$2,268	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rachel Vivian Kramer, M.D.?

Tedicare shows public-source Medicare data for Rachel Vivian Kramer, M.D. (NPI 1932108875), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachel Vivian Kramer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rachel Vivian Kramer, M.D.?

Rachel Vivian Kramer, M.D. is linked to EAST SIDE ONCOLOGY ASSOCIATES PLLC DBA AMERICAN INFUSION CENTER (billing NPI 1922287390) in the available physician profile data.

Does Rachel Vivian Kramer, M.D. have Open Payments data?

Rachel Vivian Kramer, M.D. has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.